INTRODUCTION
Concerns have been raised about health effects related to deployment of military personnel to Southwest Asia (SWA) in support of combat operations during Operations Iraqi Freedom/Enduring Freedom (OIF/OEF). The effect of deployment on the respiratory health of military personnel remains an active issue 1 . These conflicts are unique due to environmental exposures from suspended geologic dusts, burn pits for waste disposal, and localized exposures such as the Al-Mishraq sulfur fire. United States Army environmental sampling demonstrated that military personnel were exposed to increased levels of airborne particulate matter (PM)
consisting primarily of geologic dusts exceeding current exposure guidelines 2 . Based on limited evidence, the Armed Forces Health Surveillance Center concluded there was no increased risk for respiratory diseases associated with exposure to burn pits 3 . The 2011 Institute of Medicine report also concluded increased PM was a concerning issue, but there was insufficient evidence of an association between exposures and disease outcomes 4 .
Documented increases in non-specific respiratory symptoms have been reported during SWA deployments. Survey research five years after the conclusion of the First Gulf War identified a modest correlation in self-reported symptoms of asthma and bronchitis in 1560
veterans, but findings did not correlate with modeled oil fire exposures 5 . Initial results from a Navy survey of 15,000 military personnel estimated that 69% of deployed personnel experienced respiratory illnesses, of which 17% required medical care 6 . Additional data from the Millennium Cohort Study found deployed personnel had higher rates of newly reported respiratory symptoms than non-deployed personnel (14% vs. 10%), with similar rates of chronic lung disease 7 .
bronchiolitis (CB) described to involve a significant percentage of the small airways 8 . Despite these findings, spirometry was generally normal with only 16% having obstructive or restrictive indices; chest radiography (CXR) was normal in 37/38 patients while high resolution computed tomography (HRCT) showed "mild air trapping" in 16%. An epidemiologic cohort study of 191
exposed soldiers, however, demonstrated no increase in post-deployment medical encounters among personnel exposed to the sulfur fire 9 .
A 2010 Working Group on post-deployment respiratory issues recommended pulmonary referral for chronic symptoms, reduction in exercise tolerance, abnormal pulmonary function testing, comprehensive evaluation; and potential consideration for lung biopsy in patients on an individualized basis 10 . Due to predominantly retrospective studies and surveys with limited data on post-deployment respiratory disease, the Department of Defense initiated clinical research studies to examine respiratory effects of deployment. The objective of this study was to conduct a preliminary evaluation of returning military personnel to establish etiologies for new onset respiratory symptoms after service in SWA. Three replicate measurements of oscillatory resistance were obtained using system software (CareFusion MasterScreen IOS, Jaeger/Toennies). For measurement of respiratory resistance, participants were asked to breathe quietly for 15 to 20 seconds using a rigid oval mouthpiece while supporting both cheeks. Measurements of R5 (total respiratory resistance), R20 (proximal resistance), X5 (distal capacitive reactance), Fres (resonant frequency), and AX (reactance area) were recorded. Post-BD values were also recorded after administration of an inhaled levalbuterol 13 .
METHODS

This
Participants undergoing methacholine challenge testing (MCT) were required to be off pulmonary medications for one week. Increasing doses of methacholine were administered at the following concentrations: normal saline, 0.0625 mg/ml, 0.25 mg/ml, 1.0 mg/ml, 4 mg/ml, 8 mg/ml, and 16 mg/ml. Each dose was administered via five breaths through a Salter model 0700 dosimeter (Salter Labs, Arvin, CA) using an inspiratory time of 0.6 seconds. After each dose, the subject waited three minutes and performed two FVC maneuvers. This was repeated for all methacholine concentrations until maximal concentration or a 20% drop in the FEV 1 or reactive MCT in accordance with current asthma guidelines 16 . A diagnosis of nonspecific airway hyperreactivity (AHR) was established in patients with normal baseline spirometry, BD response less than 12%, reactive MCT above 4 mg/ml, or evidence increased airway resistance based on IOS criteria (R5 greater than 150% predicted and X5-X5 predicted less than -1.5). In those patients with normal full PFTS, lack of AHR, normal imaging studies, and normal BAL cell count, a specific diagnosis was not established.
Statistical analysis was performed using commercially available software (SPSS, version 16). Data are expressed as mean ± SD, unless otherwise noted. Statistical comparison for gender differences was performed with a t-test for the following variables, FVC (% predicted),
, RV (% predicted), TLC (% predicted) and DLCO (% predicted). Post hoc analysis was performed if the primary analysis failed to reach significance.
Impulse oscillometry values (pre and post bronchodilator) were compared using a paired t-test.
Cell count differentials were compared using the Kruskal-Wallis test. P values less than 0.05 were considered significant.
RESULTS
Fifty consecutive patients who met inclusion criteria completed the protocol. The group was 80% male (n=40) and 20% female (n=10) and race consisted of 58% Caucasians, 24%
Hispanics and 18% African-Americans. Mean age was 31.9 ± 8.4 years and body mass index was measured at 28.6 ± 4.3 kg/m 2 . The majority of the group (58%) never smoked and 26%
were previous smokers. Active smokers comprised 16% and averaged 0.5 packs per day. Mean cigarette use for all smokers was 5.3 ± 6.6 pack years.
Deployment surveys were completed by 42 of 50 (84%) participants. Deployment location included Iraq (64%), Afghanistan (24%), and both countries (9.5%) with mean deployment of 11.7 ± 3.6 months. Less than half (45%) reported previous military deployments in support of OIF/OEF with an average of 1.6 ± 0.7 deployments per individual with multiple deployments. General types of airborne hazard exposures included sandstorms and blowing dust (97%), burn pit smoke (92%), smoke/vehicle exhaust (86%) and various chemicals (52%).
Thirty-four (81%) individuals responded to questions on frequency and severity of exposures (Exposure: 1-occasionally, 2-regularly and 3-continuously; Severity: 0-none, 1-mild, 2-moderate, 3-severe) and is shown in Table 1 . Airborne dust/sand had the highest frequency (2.55 ± 0.50) and severity (1.71 ± 0.68) of exposure. The percentage who reported exposure-related respiratory symptoms and medical evaluations is also detailed.
During deployment, 14% reported evaluation and treatment for "asthma" symptoms, 14%
upper respiratory infections, 10% acute bronchitis, 5% influenza symptoms, and 21% rhinitis.
The study cohort reported 1.4 ± 2.0 medical visits while deployed. Prior to study evaluation, seven patients reported asthma medication use and 11 used daily allergy medications. There were continuous increases in all symptoms during deployment that continued post-deployment until study evaluation ( Figure 1 ). Additional confounding sleep and psychiatric medical issues were identified. Fifty percent of patients were evaluated for insomnia and 22% were diagnosed with obstructive sleep apnea based on objective testing. Sixty-eight percent of patients were evaluated for a mental health disorder and 54% had multiple diagnoses. Frequency of diagnoses included anxiety (42%), depression (42%), adjustment disorder (42%), post-traumatic stress disorder (32%) and traumatic brain injury (12%).
All patients completed full pulmonary function testing (PFT) (except two patients without lung volumes and DLCO) as shown in and platelets of 238 ± 41 x 10 3 . Cell counts obtained from BAL (n=47) are shown in Table 3 based on diagnosis category. Of the 8 active smokers in the study, only one patient had an elevated neutrophil count of 21% on BAL and was included in the elevated cell count group.
Methacholine challenge testing was performed in 44/50 (88%) of patients to establish the presence of AHR. Thirty-two had negative MCT studies, seven were positive and the remaining five patients had borderline hyperreactivity with a 20% decrease in FEV 1 above 4 mg/ml.
Impulse oscillometry data is shown in Table 4 Additional studies included exercise laryngoscopy in 11 patients based on spirometry findings (truncated inspiratory FVL) and one patient was diagnosed with vocal cord dysfunction.
Cardiopulmonary exercise testing (CPET) was completed in another 11 patients; six patients had a normal study, four had ventilatory limitation to exercise (three diagnosed with AHR, one undiagnosed), and one performed a submaximal study. Results of testing are shown in Table 5 and compared to the symptomatic military cohort evaluated in the 2002 Morris study 17 .
From these testing modalities, a preliminary diagnosis was established for the entire patient cohort as shown in Figure 2 . The largest percentage of patients remained undiagnosed in 42% of the cohort. This included seven of 21 patients with normal testing and an isolated increase in either neutrophils or lymphocytes on BAL. Thirty-six percent (n=18) of the patients demonstrated evidence of AHR; 16% met criteria for asthma based on baseline obstruction, BD response or a reactive MCT while the remaining 20% had nonspecific AHR. Two patients had symptoms, upper airway and PFT findings consistent with AHR secondary to gastroesophageal reflux. Four additional patients (8%) had an isolated reduced DLCO without other findings (one current smoker, two former). Miscellaneous causes were identified in six patients as shown in Figure 2 . Distribution of diagnoses for identified sleep disorders was similar for both undiagnosed (62%) and diagnosed (52%) patients. Similarly, mental health disorders were evenly divided between both groups, 69% vs. 67% respectively.
DISCUSSION
Military personnel deployed to Iraq/Afghanistan have been exposed to numerous airborne hazards due to higher levels of ambient PM 2 . Reports have implied a direct relationship between deployment PM exposure and development of serious and debilitating chronic pulmonary disease 18 . The current medical literature clearly shows increases in respiratory symptoms in deployed military, but provides minimal longitudinal data on development of chronic lung disease 7 . The 2011 Institute of Medicine report reached a similar conclusion and noted the lack of PFT data in deployed individuals 4 .
This study represents a preliminary systematic evaluation of deployed military personnel for deployment-related respiratory symptoms and evidence of lung disease. A large percentage (42%) had a non-diagnostic evaluation suggesting that symptoms may be non-specific and not necessarily indicate underlying lung disease. 23 . Dyspnea can be very subjective and may be multi-factorial to include underlying lung disease, physical conditioning, smoking, and other factors such as anxiety and hyperventilation 24 . Persons characterized by elevated anxiety may also present with medically unexplained dyspnea 25 . Important in the evaluation of deployed military personnel are underlying mental health and sleep disorders that may contribute to symptoms. Two-thirds of our overall patient cohort and those with unexplained dyspnea were diagnosed with these disorders. The contribution of these disorders to chronic respiratory symptoms in our cohort was undetermined and not readily identified during a pulmonary evaluation. Another potentially confounding factor in evaluating respiratory symptoms in deployed service members is the higher rate of tobacco use in the military and its increased use during deployment 26, 27 . However, our limited cohort did not report the same levels of cigarette smoking as previously reported.
Despite accession standards which exclude individuals with an established diagnosis of asthma over the age of 12 from military service, asthma remains a common finding in the military population 28, 29 . While asthma may be a disqualifying diagnosis, some asthma patients are given a medical waiver to enter military service, while other asthmatics are retained. Data obtained from new Army recruits identified 14% with asymptomatic AHR based on spirometric findings and exercise testing 30 . Several deployment studies have noted asthma to be a common finding. A survey of deploying Army personnel identified 5% deployed to SWA reported a previous diagnosis of asthma 31 . A limited ICD-9 review of over 6000 VA medical records noted higher rates of asthma (6.6% versus 4.3%) in deployed military between 2004 and 2007 compared to non-deployed personnel 32 . An in-depth review on asthmatics undergoing fitness for duty evaluations identified 25% of patients were diagnosed post-deployment with no differences in PFT or asthma severity shown 33 . The significant percentage of patients with either asthma or nonspecific AHR in this study concurs with previous findings 17 . Given the effects of geologic dusts and increased smoking associated with deployment, any evaluation of deployed individuals should begin with testing to identify asthma.
The 2011 publication by King et al. reported significant numbers of returning military personnel with respiratory symptoms and CB was the leading cause of respiratory illness in these individuals 8 . It is a rare diagnosis associated with environmental and occupational inhalation exposures such toxic fumes, irritant gases (sulfur dioxide), dusts, or volatile flavoring agents 34 .
Constrictive bronchiolitis has been characterized by fixed airways obstruction and fibrosis of the distal airways or bronchioles 19 , with irreversible obstruction and hyperinflation on PFTs, and HRCT evidence of air trapping and mosaicism 35, 36 . In the King series, evaluation in these patients was primarily limited to full PFTs, HRCT, and CPET. Methacholine challenge testing was only performed in 32% and no post-bronchodilator testing was reported. Computed tomography imaging likewise only showed "mild air trapping" in 16% and the typical radiographic mosaicism pattern was not described. Additionally, since this histopathologic description of CB did not match physiologic findings and was not responsive to therapy, we could not justify performing biopsies in the absence of HRCT changes.
Military physicians remain aware of the cluster of acute eosinophilic pneumonia cases identified at Landstuhl Regional Medical Center associated with new-onset smoking 37 . Our Longitudinal studies are being conducted with deployed military to define the potential for chronic pulmonary disorders. Finally, the role of mental health and sleep disorders on symptoms of dyspnea in this population needs further investigation. Cell counts from bronchoalveolar lavage based on final diagnosis. Undiagnosed includes 13 patients with normal testing and 7 patients with normal testing and an isolated cell count abnormality. Cell count differentials were compared using the Kruskal-Wallis test. Miscellaneous category includes individual patients with the following diagnosis: vocal cord dysfunction (also diagnosed with asthma), chronic obstructive pulmonary disease, lung nodule, fixed airway obstruction, inhalational injury, and isolated air trapping. 
